Photo from wikipedia
To evaluate the serologic response to the BNT162b2 messenger ribonucleic acid vaccine in patients with urothelial carcinoma and renal cell carcinoma. Click to show full abstract
To evaluate the serologic response to the BNT162b2 messenger ribonucleic acid vaccine in patients with urothelial carcinoma and renal cell carcinoma.
Keywords:
cell carcinoma;
renal cell;
vaccine patients;
serologic response;
patients urothelial
Journal Title: International Journal of Urology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Urology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!